Article citationsMore >>

Surget S, Khoury MP, Bourdon JC (2013). Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. OncoTargets and Therapy; 7: 57-68.

has been cited by the following article:

Article

Tumor Protein p53: Novel Aspects of an Old Tumor Marker

1Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia

2Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt


Journal of Cancer Research and Treatment. 2015, Vol. 3 No. 2, 25-27
DOI: 10.12691/jcrt-3-2-2
Copyright © 2015 Science and Education Publishing

Cite this paper:
Ahmed M. Kabel. Tumor Protein p53: Novel Aspects of an Old Tumor Marker. Journal of Cancer Research and Treatment. 2015; 3(2):25-27. doi: 10.12691/jcrt-3-2-2.

Correspondence to: Ahmed  M. Kabel, Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia. Email: drakabel@gmail.com

Abstract

P53 gene is a tumor suppressor gene that stops the formation of tumors. If a person inherits only one functional copy of the p53 gene from his parents, he will be predisposed to cancer and usually develop several tumors in various tissues in early adulthood. However, mutations in p53 are found in most tumor types, and so contribute to a number of molecular events leading to tumor formation. There are numerous informations that exist on all aspects of p53 normal function and mutant expression in human cancers, reflecting its key role in the pathogenesis of human cancers.

Keywords